Evidence map›Paper›PMID 24772213›Full record

ArticleTranslational oncology2014

Image registration for quantitative parametric response mapping of cancer treatment response.

Jennifer L Boes, Benjamin A Hoff, Nola Hylton, Martin D Pickles, Lindsay W Turnbull, Anne F Schott, Alnawaz Rehemtulla, Ryan Chamberlain, Benjamin Lemasson, Thomas L Chenevert and 3 more

Open access · goldAbstract read
In one paragraph

Article in Translational oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A PRM approach for early prediction of breast cancer response to chemotherapy based on registered MR images.International journal of computer assisted radiology and surgery · 2018
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Jennifer L BoesDepartment of Radiology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Benjamin A HoffDepartment of Radiology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Nola HyltonDepartments of Radiology and Biomedical Engineering, University of California at San Francisco, San Francisco, CA.
Martin D PicklesCentre for MR Investigations, Hull York Medical School, University of Hull, Hull, UK.
Lindsay W TurnbullCentre for MR Investigations, Hull York Medical School, University of Hull, Hull, UK.
Anne F SchottDepartment of Internal Medicine, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Alnawaz RehemtullaDepartment of Radiation Oncology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Ryan ChamberlainImbio, Minneapolis, MN.
Benjamin LemassonINSERM U836, F-38042, Université Joseph Fourier, Institut des Neurosciences, UMR-S836, Grenoble, France.
Thomas L ChenevertDepartment of Radiology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Craig J GalbánDepartment of Radiology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Charles R MeyerDepartment of Radiology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
Brian D RossDepartment of Radiology, Center for Molecular Imaging, University of Michigan, Ann Arbor, MI.
University of Michigan–Ann Arbor · USHull York Medical School · GBImbio (United States) · USInserm · FRUniversity of California, San Francisco · US

Funding

QUANTITATION OF HUMAN BRAIN TUMOR THERAPY RESPONSE BY MRP01CA085878 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROSS, BRIAN D. · 2001 to 2017
$31.9M
Presurgical Planning with Optimized Verbalized Speech Activation Studies inP01CA087634 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FESSLER, JEFFREY A · 2002 to 2013
$14.8M
Quantitative DW-MRI for Early Breast Cancer Treatment Response AssessmentU01CA166104 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENEVERT, THOMAS L, GALBAN, CRAIG J · 2012 to 2019
$4.1M
Quantitative Imaging for Assessing Breast Cancer Response to TreatmentU01CA151235 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M. · 2011 to 2015
$2.8M
Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the BoneR01CA136892 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROSS, BRIAN D. · 2009 to 2012
$2.1M
Training Future Imaging Scientists for BiomedicineT32EB005172 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FOWLKES, JEFFREY B · 2008 to 2012
$1.1M
NCI NIH HHS N01 CA032102NCI NIH HHS P01 CA085878NCI NIH HHS P01 CA087634NCI NIH HHS R01 CA136892NCI NIH HHS U01 CA151235NCI NIH HHS U01 CA166104NIBIB NIH HHS T32 EB005172
6 · The paper itself

Abstract

Imaging biomarkers capable of early quantification of tumor response to therapy would provide an opportunity to individualize patient care. Image registration of longitudinal scans provides a method of detecting treatment associated changes within heterogeneous tumors by monitoring alterations in the quantitative value of individual voxels over time, which is unattainable by traditional volumetric-based histogram methods. The concepts involved in the use of image registration for tracking and quantifying breast cancer treatment response using parametric response mapping (PRM), a voxel-based analysis of diffusion-weighted magnetic resonance imaging (DW-MRI) scans, are presented. Application of PRM to breast tumor response detection is described, wherein robust registration solutions for tracking small changes in water diffusivity in breast tumors during therapy are required. Methodologies that employ simulations are presented for measuring expected statistical accuracy of PRM for response assessment. Test-retest clinical scans are used to yield estimates of system noise to indicate significant changes in voxel-based changes in water diffusivity. Overall, registration-based PRM image analysis provides significant opportunities for voxel-based image analysis to provide the required accuracy for early assessment of response to treatment in breast cancer patients receiving neoadjuvant chemotherapy.

Identifiers

PMID24772213
PMCPMC3998680
OpenAlexW1980689943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.